Lidorestat (IDD 676) for the Treatment of Diabetic Neuropathy

Status Active, not recruiting

Clinical Trial Summary

This clinical trial is to determine an effective dosage and to study the safety of an investigational drug -lidorestat (IDD-676)- which is intended to stop or slow the progression of diabetic peripheral neuropathy.

Clinical Trial Description

Diabetic peripheral neuropathy is one of the most important and serious complications of diabetes. It can cause pain and loss of sensation, loss of mobility and lead to chronic wounds and amputations. Studies indicate 50% or more of people who have diabetes now have or will have significant neuropathy.

Several currently marketed or investigational drugs are available to treat the painful symptoms of diabetic peripheral neuropathy, but there are no approved drugs that have been shown to prevent or slow the progression of the neuropathy itself.

The current clinical trial is an early phase II study designed to investigate the safety of the investigational drug lidorestat (IDD-676) and to determine the effect of various dose levels on important biochemical processes in the pathology of diabetic neuropathy.

Participants who enter and complete this study will, if the agent is successful, help in a very important way to bring an effective treatment from research laboratories to widespread availability for treatment. On the basis of the results of this study, large scale studies will be undertaken to support application for product registration and distribution in the U.S. and other countries throughout the world. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00043797
Study type	Interventional
Source	The Institute for Diabetes Discovery, LLC
Contact
Status	Active, not recruiting
Phase	Phase 2

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06040567` - Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study
Completed	`NCT02423434` - Evaluation of Corneal Confocal Microscopy for the Identification and Prediction of Neuropathy in Type 1 Diabetes
Completed	`NCT05542901` - Comparison of Joint Position Sense in Diabetic and Traumatic Transtibial Amputees	N/A
Withdrawn	`NCT01536236` - Spinal Cord Stimulation for Diabetic Polyneuropathy	N/A
Active, not recruiting	`NCT01175928` - Pneumatic Medicine: A Transformative Treatment for Diabetic Peripheral Neuropathy	Phase 1/Phase 2
Completed	`NCT00993070` - Efficacy and Safety Study of Topical Capsaicin in Painful Diabetic Neuropathy	Phase 2/Phase 3
Completed	`NCT00539175` - Treatment of Painful Diabetic Neuropathy With Photon Stimulation	N/A
Completed	`NCT00278980` - Effect of C-Peptide on Diabetic Peripheral Neuropathy	Phase 2
Completed	`NCT04593992` - HTEMS Treatment of Diabetic Polyneuropathy	N/A
Completed	`NCT01465620` - Dietetic and Hygiene Measures in Metabolic Neuropathies: the Neurodiet Study	Phase 3
Completed	`NCT01079325` - Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy	Phase 2
Completed	`NCT00406458` - Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy	Phase 2
Recruiting	`NCT06071975` - Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy	Phase 3
Recruiting	`NCT06072573` - Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy	Phase 3
Recruiting	`NCT05521737` - Effect of Electroacupuncture on Sensitive Symptoms of Distal Diabetic Peripheral Neuropathy	N/A
Completed	`NCT01847937` - Magnetic Resonance Diagnostics of Diabetic Peripheral Neuropathy	N/A
Completed	`NCT00476931` - Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy	Phase 2
Completed	`NCT00977483` - Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)	Phase 3
Completed	`NCT01006915` - Surgical Decompression for Diabetic Neuropathy in the Foot	N/A
Completed	`NCT00501202` - Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN).	Phase 2